.

Name : Ms. CHITRA AGGARWAL

Lab No. : 456068234 Age : 61 Years
Ref By : SELF Gender : Female
Collected : 25/4/2024 6:40:00AM Reported : 25/4/2024 4:49:40PM
A/c Status : P Report Status : Final
Collected at : GGN-HOME VISIT Processed at : LPL-GURGAON
102, GALLERIA MARKET DLF-IV C1/B, Clear View Building Old DLF Colony,
GURGAON Sector-14 Gurgaon, Haryana-122001

Test Report

Test Name Results Units Bio. Ref. Interval

SWASTHFIT COMPLETE HEALTH CHECK.

LIVER & KIDNEY PANEL, SERUM

Creatinine 0.74 mg/dL 0.51 - 0.95

(Compensated Jaffes reaction, IDMS traceable)
GFR Estimated 92 mL/min/1.73m2 >59
(CKD EPI Equation 2021)
GFR Category G1
(KDIGO Guideline 2012)
Urea 42.30 mg/dL 17.00 - 43.00
(Urease UV)
Urea Nitrogen Blood 19.75 mg/dL 8.00 - 23.00
(Urease UV)
BUN/Creatinine Ratio 27
(Calculated)
Uric Acid 3.30 mg/dL 2.60 - 6.00
(Uricase)
AST (SGOT) 22.7 U/L <35
(IFCC)
ALT (SGPT) 12.2 U/L <35
(IFCC)
GGTP 14.0 U/L <38
(IFCC)
Alkaline Phosphatase (ALP) 47.00 U/L 30 - 120
(IFCC)
Bilirubin Total 0.66 mg/dL 0.20 - 1.10
(DPD)
Bilirubin Direct 0.17 mg/dL <0.2
(DPD)
Bilirubin Indirect 0.49 mg/dL <1.10
(Calculated)
Total Protein 6.87 g/dL 6.40 - 8.10
(Biuret)
Albumin 4.06 g/dL 3.20 - 4.60
(Bromocresol Green)
A : G Ratio 1.44 0.90 - 2.00
(Calculated)
Globulin(Calculated) 2.81 gm/dL 2.0 - 3.5

Calcium, Total 9.15 mg/dL 8.80 - 10.20

(Arsenazo III)

*456068234* Page 1 of 12
.

Name : Ms. CHITRA AGGARWAL

Lab No. : 456068234 Age : 61 Years
Ref By : SELF Gender : Female
Collected : 25/4/2024 6:40:00AM Reported : 25/4/2024 4:49:40PM
A/c Status : P Report Status : Final
Collected at : GGN-HOME VISIT Processed at : LPL-GURGAON
102, GALLERIA MARKET DLF-IV C1/B, Clear View Building Old DLF Colony,
GURGAON Sector-14 Gurgaon, Haryana-122001

Test Report

Test Name Results Units Bio. Ref. Interval

Phosphorus 4.25 mg/dL 2.80 - 4.00
(Molybedate UV)
Sodium 139.70 mEq/L 136.00 - 146.00
(Indirect ISE)
Potassium 4.33 mEq/L 3.50 - 5.10
(Indirect ISE)
Chloride 107.10 mEq/L 101.00 - 109.00
(Indirect ISE)

*456068234* Page 2 of 12
.

Name : Ms. CHITRA AGGARWAL

Lab No. : 456068234 Age : 61 Years
Ref By : SELF Gender : Female
Collected : 25/4/2024 6:40:00AM Reported : 25/4/2024 4:49:40PM
A/c Status : P Report Status : Final
Collected at : GGN-HOME VISIT Processed at : LPL-GURGAON
102, GALLERIA MARKET DLF-IV C1/B, Clear View Building Old DLF Colony,
GURGAON Sector-14 Gurgaon, Haryana-122001

Test Report

Test Name Results Units Bio. Ref. Interval

LIPID SCREEN, SERUM

Cholesterol, Total 97.00 mg/dL <200.00

(CHO-POD)
Triglycerides 93.00 mg/dL <150.00
(GPO-POD Enzymatic)
HDL Cholesterol 40.10 mg/dL >50.00
(Enzymatic Immunoinhibition)
LDL Cholesterol, Calculated 38.30 mg/dL <100.00
(Calculated)
VLDL Cholesterol,Calculated 18.60 mg/dL <30.00
(Calculated)
Non-HDL Cholesterol 57 mg/dL <130
(Calculated)

Note
1. Measurements in the same patient can show physiological & analytical variations. Three serial
samples 1 week apart are recommended for Total Cholesterol, Triglycerides, HDL& LDL Cholesterol.
2. Additional testing for Apolipoprotein B, hsCRP, Lp(a ) & LP-PLA2 should be considered
among patients with moderate risk for ASCVD for risk refinement.

Treatment Goals as per Lipid Association of India 2020

--------------------------------------------------------------------------------------------
| RISK | TREATMENT GOAL | CONSIDER THERAPY |
| CATEGORY |-----------------------------------------|-------------------------------------|
| | LDL CHOLESTEROL | NON HDL CHLOESTEROL| LDL CHOLESTEROL| NON HDL CHLOESTEROL|
| | (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)| (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)|
|------------|--------------------|--------------------|----------------|--------------------|
| Extreme | <50 | <80 | | |
| Risk Group |(Optional goal ≤30) |(Optional goal ≤60) | ≥50 | ≥80 |
| Category A | | | | |
|------------|--------------------|--------------------|----------------|--------------------|
| Extreme | | | | |
| Risk Group | ≤30 | ≤60 | >30 | >60 |
| Category B | | | | |
|------------|--------------------|--------------------|----------------|--------------------|
| Very | <50 | <80 | ≥50 | ≥80 |
| High | | | | |
|------------|--------------------|--------------------|----------------|--------------------|
| High | <70 | <100 | ≥70 | ≥100 |
|------------|--------------------|--------------------|----------------|--------------------|
| Moderate | <100 | <130 | ≥100 | ≥130 |
|------------|--------------------|--------------------|----------------|--------------------|
| Low | <100 | <130 | ≥130* | ≥160* |
--------------------------------------------------------------------------------------------
*In low risk patient, consider therapy after an initial non-pharmacological intervention for at least 3 months

*456068234* Page 3 of 12
.

Name : Ms. CHITRA AGGARWAL

Lab No. : 456068234 Age : 61 Years
Ref By : SELF Gender : Female
Collected : 25/4/2024 6:40:00AM Reported : 25/4/2024 4:49:40PM
A/c Status : P Report Status : Final
Collected at : GGN-HOME VISIT Processed at : LPL-GURGAON
102, GALLERIA MARKET DLF-IV C1/B, Clear View Building Old DLF Colony,
GURGAON Sector-14 Gurgaon, Haryana-122001

Test Report

Test Name Results Units Bio. Ref. Interval

GLUCOSE, FASTING (F)

(Hexokinase)

Glucose Fasting 91.00 mg/dL 70.00 - 100.00

VITAMIN D, 25 - HYDROXY, SERUM

(CLIA)

Vitamin D, 25 Hydroxy 64.11 nmol/L 75.00 - 250

Interpretation
--------------------------------------------------------------------------------------------
| LEVEL | REFERENCE RANGE IN nmol/L| COMMENTS |
|---------------|--------------------------|-------------------------------------------------|
| Deficient | < 50 | High risk for developing bone disease |
|---------------|--------------------------|-------------------------------------------------|
| Insufficient | 50-74 | Vitamin D concentration which normalizes |
| | | Parathyroid hormone concentration |
|---------------|--------------------------|-------------------------------------------------|
| Sufficient | 75-250 | Optimal concentration for maximal health benefit|
|---------------|--------------------------|-------------------------------------------------|
| Potential | >250 | High risk for toxic effects |
| intoxication | | |
--------------------------------------------------------------------------------------------
Note
· The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D.
· 25 (OH)D is influenced by sunlight, latitude, skin pigmentation, sunscreen use and hepatic function.
· Optimal calcium absorption requires vitamin D 25 (OH) levels exceeding 75 nmol/L.
· It shows seasonal variation, with values being 40-50% lower in winter than in summer.
· Levels vary with age and are increased in pregnancy.
· A new test Vitamin D, Ultrasensitive by LC-MS/MS is also available

THYROID PROFILE,TOTAL, SERUM

(CLIA)

T3, Total 0.55 ng/mL 0.40 - 1.81

T4, Total 8.73 µg/dL 5.74 - 13.03

*456068234* Page 4 of 12
.

Name : Ms. CHITRA AGGARWAL

Lab No. : 456068234 Age : 61 Years
Ref By : SELF Gender : Female
Collected : 25/4/2024 6:40:00AM Reported : 25/4/2024 4:49:40PM
A/c Status : P Report Status : Final
Collected at : GGN-HOME VISIT Processed at : LPL-GURGAON
102, GALLERIA MARKET DLF-IV C1/B, Clear View Building Old DLF Colony,
GURGAON Sector-14 Gurgaon, Haryana-122001

Test Report

Test Name Results Units Bio. Ref. Interval

TSH 0.89 µIU/mL 0.35 - 5.50

Note
1. TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a
minimum between 6-10 pm . The variation is of the order of 50% . hence time of the day has
influence on the measured serum TSH concentrations.
2. Alteration in concentration of Thyroid hormone binding protein can profoundly affect Total T3 and/or
Total T4 levels especially in pregnancy and in patients on steroid therapy.
3. Unbound fraction ( Free,T4 /Free,T3) of thyroid hormone is biologically active form and correlate
more closely with clinical status of the patient than total T4/T3 concentration
4. Values <0.03 uIU/mL need to be clinically correlated due to presence of a rare TSH variant in
some individuals

AMYLASE, SERUM
(IFCC)

Amylase 106.00 U/L 28.00 - 100.00

IRON STUDIES, SERUM

(Spectrophotometry, TPTZ, NITROSO – PSAP, Calculated)

Iron 37.30 µg/dL 50.00 - 170.00

Total Iron Binding Capacity (TIBC) 488.30 µg/dL 250.00 - 425.00

Transferrin Saturation 7.64 % 15.00 - 50.00

*456068234* Page 5 of 12
.

Name : Ms. CHITRA AGGARWAL

Lab No. : 456068234 Age : 61 Years
Ref By : SELF Gender : Female
Collected : 25/4/2024 6:40:00AM Reported : 25/4/2024 4:49:40PM
A/c Status : P Report Status : Final
Collected at : GGN-HOME VISIT Processed at : LPL-GURGAON
102, GALLERIA MARKET DLF-IV C1/B, Clear View Building Old DLF Colony,
GURGAON Sector-14 Gurgaon, Haryana-122001

Test Report

Test Name Results Units Bio. Ref. Interval

VITAMIN B12; CYANOCOBALAMIN

(ECLIA)

Vitamin B12; Cyanocobalamin 649.10 pg/mL 211.00 - 946.00

Notes
1. Interpretation of the result should be considered in relation to clinical circumstances.
2. It is recommended to consider supplementary testing with plasma Methylmalonic acid (MMA) or
plasma homocysteine levels to determine biochemical cobalamin deficiency in presence of clinical
suspicion of deficiency but indeterminate levels. Homocysteine levels are more sensitive but MMA is
more specific

3. False increase in Vitamin B12 levels may be observed in patients with intrinsic factor blocking
antibodies, MMA measurement should be considered in such patients

4. The concentration of Vitamin B12 obtained with different assay methods cannot be used
interchangeably due to differences in assay methods and reagent specificity

*456068234* Page 6 of 12
.

Name : Ms. CHITRA AGGARWAL

Lab No. : 456068234 Age : 61 Years
Ref By : SELF Gender : Female
Collected : 25/4/2024 6:40:00AM Reported : 25/4/2024 4:49:40PM
A/c Status : P Report Status : Final
Collected at : GGN-HOME VISIT Processed at : LPL-GURGAON
102, GALLERIA MARKET DLF-IV C1/B, Clear View Building Old DLF Colony,
GURGAON Sector-14 Gurgaon, Haryana-122001

Test Report

Test Name Results Units Bio. Ref. Interval

HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD
(HPLC, NGSP certified)

HbA1c 6.1 % 4.00 - 5.60

Estimated average glucose (eAG) 128 mg/dL

Interpretation
HbA1c result is suggestive of at risk for Diabetes (Prediabetes)/ well controlled Diabetes in a known Diabetic
Interpretation as per American Diabetes Association (ADA) Guidelines

------------------------------------------------------------------------------------------
| Reference Group | Non diabetic | At risk | Diagnosing | Therapeutic goals |
| | adults >=18 years | (Prediabetes) | Diabetes | for glycemic control |
| ----------------|-------------------|---------------|-------------|----------------------|
| HbA1c in % | 4.0-5.6 | 5.7-6.4 | >= 6.5 | <7.0 |
------------------------------------------------------------------------------------------

Note: Presence of Hemoglobin variants and/or conditions that affect red cell turnover must be considered,
particularly when the HbA1C result does not correlate with the patient’s blood glucose levels.

---------------------------------------------------------------------------------
| FACTORS THAT INTERFERE WITH HbA1C | FACTORS THAT AFFECT INTERPRETATION |
| MEASUREMENT | OF HBA1C RESULTS |
|--------------------------------------|------------------------------------------|
| Hemoglobin variants,elevated fetal | Any condition that shortens erythrocyte |
| hemoglobin (HbF) and chemically | survival or decreases mean erythrocyte |
| modified derivatives of hemoglobin | age (e.g.,recovery from acute blood loss,|
| (e.g. carbamylated Hb in patients | hemolytic anemia, HbSS, HbCC, and HbSC) |
| with renal failure) can affect the | will falsely lower HbA1c test results |
| accuracy of HbA1c measurements | regardless of the assay method used.Iron |
| | deficiency anemia is associated with |
| | higher HbA1c |
---------------------------------------------------------------------------------

*456068234* Page 7 of 12
.

Name : Ms. CHITRA AGGARWAL

Lab No. : 456068234 Age : 61 Years
Ref By : SELF Gender : Female
Collected : 25/4/2024 6:40:00AM Reported : 25/4/2024 4:49:40PM
A/c Status : P Report Status : Final
Collected at : GGN-HOME VISIT Processed at : LPL-GURGAON
102, GALLERIA MARKET DLF-IV C1/B, Clear View Building Old DLF Colony,
GURGAON Sector-14 Gurgaon, Haryana-122001

Test Report

Test Name Results Units Bio. Ref. Interval

C-REACTIVE PROTEIN, CARDIO; hsCRP 0.85 mg/L <1.00

(Immunoturbidimetry)
Interpretation
--------------------------------------------------------------
| CARDIO CRP IN mg/L | CARDIOVASCULAR RISK |
|-----------------------|--------------------------------------|
| <1 | Low |
|-----------------------|--------------------------------------|
| 1-3 | Average |
|-----------------------|--------------------------------------|
| 3-10 | High |
|-----------------------|--------------------------------------|
| >10 | Persistent elevation may represent |
| | Non cardiovascular inflammation |
--------------------------------------------------------------

*456068234* Page 8 of 12
.

Name : Ms. CHITRA AGGARWAL

Lab No. : 456068234 Age : 61 Years
Ref By : SELF Gender : Female
Collected : 25/4/2024 6:40:00AM Reported : 25/4/2024 4:49:40PM
A/c Status : P Report Status : Final
Collected at : GGN-HOME VISIT Processed at : LPL-GURGAON
102, GALLERIA MARKET DLF-IV C1/B, Clear View Building Old DLF Colony,
GURGAON Sector-14 Gurgaon, Haryana-122001

Test Report

Test Name Results Units Bio. Ref. Interval

APOLIPOPROTEINS A1 & B, SERUM

(Immunoturbidimetry, Calculated)

Apolipoprotein (Apo A1) 117 mg/dL 105.00 - 205.00

Apolipoprotein (Apo B) 45 mg/dL 55.00 - 130.00

Apo B / Apo A1 Ratio 0.38 0.35 - 0.98

As per recommendations of National Cholesterol Education Program (NCEP) the clinical

significance of results is as follows:

Apolipoprotein B
-----------------------------------------------------------------------------
| RESULT IN mg/dL | REMARKS |
|--------------------------|-------------------------------------------------|
| <23 |Abetalipoproteinemia/Hypobetalipoproteinemia |
|--------------------------|-------------------------------------------------|
| 23-45 |Hypobetalipoproteinemia |
|--------------------------|-------------------------------------------------|
| 46-135 |Normal |
| -------------------------|-------------------------------------------------|
| >135 |Hyperapobetalipoproteinemia/Increased CAD risk |
--------------------------|-------------------------------------------------
Apo B to A1 Ratio
-------------------------------
| RATIO | REMARKS |
|------------|------------------|
| 0.35-0.98 | Desirable |
|------------|------------------|
| >0.98 |Increased CAD risk|
-------------------------------

*456068234* Page 9 of 12
.

Name : Ms. CHITRA AGGARWAL

Lab No. : 456068234 Age : 61 Years
Ref By : SELF Gender : Female
Collected : 25/4/2024 6:40:00AM Reported : 25/4/2024 4:49:40PM
A/c Status : P Report Status : Final
Collected at : GGN-HOME VISIT Processed at : LPL-GURGAON
102, GALLERIA MARKET DLF-IV C1/B, Clear View Building Old DLF Colony,
GURGAON Sector-14 Gurgaon, Haryana-122001

Test Report

Test Name Results Units Bio. Ref. Interval

URINE EXAMINATION, ROUTINE; URINE, R/E
(Automated Strip Test, Microscopy)

Physical

Colour Pale Yellow Pale yellow

Specific Gravity 1.015 1.001 - 1.030

pH 5 5.0 - 8.0

Chemical

Proteins Negative Negative

Glucose Present 3+(1.0 g/dL) Negative

Ketones Negative Negative

Bilirubin Negative Negative

Urobilinogen Negative Negative

Leucocyte Esterase Negative Negative

Nitrite Negative Negative

Microscopy

R.B.C. Negative 0.0 - 2.0 RBC/hpf

Pus Cells 3-4 WBC/HPF 0-5 WBC / hpf

Epithelial Cells 0-1 Epi Cells/hpf 0.0 - 5.0 Epi

cells/hpf
Casts None seen None seen/Lpf

Crystals None seen None seen

Others None seen None seen

Result Rechecked,
Please Correlate Clinically.

Result Rechecked,
Please Correlate Clinically.

*456068234*
Page 10 of 12
.

Name : Ms. CHITRA AGGARWAL

Lab No. : 456068234 Age : 61 Years
Ref By : SELF Gender : Female
Collected : 25/4/2024 6:40:00AM Reported : 25/4/2024 4:49:40PM
A/c Status : P Report Status : Final
Collected at : GGN-HOME VISIT Processed at : LPL-GURGAON
102, GALLERIA MARKET DLF-IV C1/B, Clear View Building Old DLF Colony,
GURGAON Sector-14 Gurgaon, Haryana-122001

Test Report

Test Name Results Units Bio. Ref. Interval

HEMOGRAM
(DC Detection, Flow Cytometry, SLS, & Capillary photometry)
Hemoglobin 8.90 g/dL 12.00 - 15.00

Packed Cell Volume (PCV) 31.10 % 36.00 - 46.00

RBC Count 3.72 mill/mm3 3.80 - 4.80

MCV 83.60 fL 83.00 - 101.00

MCH 23.90 pg 27.00 - 32.00

MCHC 28.60 g/dL 31.50 - 34.50

Red Cell Distribution Width (RDW) 16.20 % 11.60 - 14.00

Total Leukocyte Count (TLC) 5.02 thou/mm3 4.00 - 10.00

Differential Leucocyte Count (DLC)

Segmented Neutrophils 60.50 % 40.00 - 80.00
Lymphocytes 30.30 % 20.00 - 40.00
Monocytes 7.20 % 2.00 - 10.00
Eosinophils 1.60 % 1.00 - 6.00
Basophils 0.40 % <2.00
Absolute Leucocyte Count
Neutrophils 3.04 thou/mm3 2.00 - 7.00
Lymphocytes 1.52 thou/mm3 1.00 - 3.00
Monocytes 0.36 thou/mm3 0.20 - 1.00
Eosinophils 0.08 thou/mm3 0.02 - 0.50
Basophils 0.02 thou/mm3 0.02 - 0.10

Platelet Count 195 thou/mm3 150.00 - 410.00

Mean Platelet Volume 13.2 fL 6.5 - 12.0

E.S.R. 11 mm/hr 0.00 - 30.00

*456068234* Page 11 of 12
.

Name : Ms. CHITRA AGGARWAL

Lab No. : 456068234 Age : 61 Years
Ref By : SELF Gender : Female
Collected : 25/4/2024 6:40:00AM Reported : 25/4/2024 4:49:40PM
A/c Status : P Report Status : Final
Collected at : GGN-HOME VISIT Processed at : LPL-GURGAON
102, GALLERIA MARKET DLF-IV C1/B, Clear View Building Old DLF Colony,
GURGAON Sector-14 Gurgaon, Haryana-122001

Test Report

Test Name Results Units Bio. Ref. Interval

Note
1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood
2. Test conducted on EDTA whole blood

Dr Parul Joshi Dr Rachna Malik

MD, Pathology MD, Pathology
Chief of Laboratory Consultant Pathologist
Dr Lal PathLabs Ltd Dr Lal PathLabs Ltd

-------------------------------End of report --------------------------------

AHEEEHAPMKHJBKCNLCAPKLPCBILLJCECCJLCIKPJPKEDFNFAPPAHEEEHA
BNFFFNBPAPBCECMGFGEKFOIPAOAHFHALAKNOBCJKJLEKMCJHMPBNFFFNB
CIEGFCFLLOMLKBJOPFIAAJHFJGFEHEDDLKPHENFLMLKIOEFLBKHDEHANP
DJEOMMFNBGKIEDIJHKOELFMFAFHKAKAFJIFFOAOAKCLJPDNLIFNBKEMEK
KDFNLHFJOFJFDIAIPFECKPJEIENJOLCHKKMHEIGIPLKGKPNGKFFFOOMJC
GACBBEFNNICGDIEKIHEAIIPBADHFOFAINDFCBKDLALIKOMNALNEIOGECL
HLIMIJFJELONMAHIEKMGBFEHIHAFJBALPFMPBLMAIJCHKJNIAJNFMDILD
NJJJAMFMBLMMMAPJGANHDEAILLBMFMBDOFCCAMNNIIKNOPNKBNFNBHILL
NKAKIMFFJIAGFAAKAPMIHMEKHMEFEKFBJFFKBLPFOOBIOCNKDJPHNEKLJ
PPBALBFCEDBJJDCJABCFGPNFKDFKPNJHKEPDEFNLNKCKIGEOCNKKHJAJL
KCIKOLFLGKCBMPDMPFJGFJEEINMNFANBJMFEBFOFPNDMKPFKEPCIGCIMG
AGICGJFCPLDDFJJMHHGIANAEIEOPPFOFBCFPBLNOOLJBIKNINKONHDICL
MNNNNNEPKFDOHKGJOCFLHBFHJBAHFHADPKPFCMNLMKJCLFNMAHFHAHIKL
APBBBPAPBHLAEJBLEOBKCJOFAGFCHHCAONFEOLOGOLMHNLNNEDFCCBKHH
HHHHHHHPHPHPHPPPHPPPPPHHHHPPPPPPPPPHHPPPPHHHPHPHHHHPPHPHP

IMPORTANT INSTRUCTIONS
ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory .
ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .ŸReport
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost
for derivation of exact value. Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations .ŸThe
Courts/Forum at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).ŸTest results are not valid
for medico legal purposes.ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical
Practitioner/Doctor. ŸThe report does not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: lalpathlabs@lalpathlabs.com

*456068234* Page 12 of 12